Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Elinder

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Haematology|April 20, 2004
Safety of rituximab therapy during the first trimester of pregnancy: a case historyEva Kimby, Asgerdur Sverrisdottir, Göran Elinder
Journal of Pediatric Hematology/Oncology|April 25, 2002
Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infectionsGunnar Skeppner, Anders Kreuger, Göran Elinder
Journal of Pediatric Hematology/Oncology|February 7, 2003
Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpuraIris Hedlund-Treutiger, Jan-Inge Henter, Göran Elinder
Education for Health (Abingdon, England)|January 27, 2004
Centres for Clinical Education (CCE): developing the health care education of tomorrow--a preliminary reportEster Mogensen, Göran Elinder, Ann-Marie Widström, et al.
Scandinavian Journal of Gastroenterology|March 28, 2008
Increased risk of immune thrombocytopenic purpura among inpatients with coeliac diseaseOla Olén, Scott M Montgomery, Göran Elinder, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 29, 2017
Insufficient evidence for 'shaken baby syndrome' - a systematic reviewNiels Lynøe, Göran Elinder, Boubou Hallberg, et al.
British Journal of Haematology|June 17, 2004
Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropeniaGöran Carlsson, Anders Ahlin, Göran Dahllöf, et al.
Archives of Disease in Childhood|April 27, 2007
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?Iris Treutiger, Jukka Rajantie, Bernward Zeller, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 7, 2006
Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countriesIris Treutiger, Jukka Rajantie, Bernward Zeller, et al.
Pediatric Blood & Cancer|June 6, 2009
Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalitiesGöran Carlsson, Göran Elinder, Helena Malmgren, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Haematology|April 20, 2004
Safety of rituximab therapy during the first trimester of pregnancy: a case historyEva Kimby, Asgerdur Sverrisdottir, Göran Elinder
Journal of Pediatric Hematology/Oncology|April 25, 2002
Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infectionsGunnar Skeppner, Anders Kreuger, Göran Elinder
Journal of Pediatric Hematology/Oncology|February 7, 2003
Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpuraIris Hedlund-Treutiger, Jan-Inge Henter, Göran Elinder
Education for Health (Abingdon, England)|January 27, 2004
Centres for Clinical Education (CCE): developing the health care education of tomorrow--a preliminary reportEster Mogensen, Göran Elinder, Ann-Marie Widström, et al.
Scandinavian Journal of Gastroenterology|March 28, 2008
Increased risk of immune thrombocytopenic purpura among inpatients with coeliac diseaseOla Olén, Scott M Montgomery, Göran Elinder, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 29, 2017
Insufficient evidence for 'shaken baby syndrome' - a systematic reviewNiels Lynøe, Göran Elinder, Boubou Hallberg, et al.
British Journal of Haematology|June 17, 2004
Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropeniaGöran Carlsson, Anders Ahlin, Göran Dahllöf, et al.
Archives of Disease in Childhood|April 27, 2007
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?Iris Treutiger, Jukka Rajantie, Bernward Zeller, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 7, 2006
Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countriesIris Treutiger, Jukka Rajantie, Bernward Zeller, et al.
Pediatric Blood & Cancer|June 6, 2009
Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalitiesGöran Carlsson, Göran Elinder, Helena Malmgren, et al.
Pageof 2